Toumpoulis Ioannis K, Kanistras Dimitrios A, Pappa Christina K, Zagoriti Zoi, Anagnostopoulos Constantine E, Toumpoulis Stavros K
Department of Cardiac Surgery, Mouwasat Hospital, Dammam 32263, Saudi Arabia.
Department of Cardiac Surgery, National and Kapodistrian University of Athens, 12462 Athens, Greece.
J Cardiovasc Dev Dis. 2022 Nov 2;9(11):375. doi: 10.3390/jcdd9110375.
Background: This study aimed to verify the external validation of a contemporary nomogram in predicting long-term survival after an isolated coronary artery bypass with bilateral internal thoracic artery grafting (CABG-BITA). Methods: Consecutive patients who underwent CABG-BITA at a single center were included in the study. All the predictors of the original risk score (age, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, chronic renal failure, old myocardial infarction, ejection fraction, intra-aortic balloon pump and peripheral arterial disease) were available for analysis. Results: Among the 2846 consecutive patients, a total of 1176 (41.3%) deaths were recorded during the 31,383 patient years of follow-up. The median EuroSCORE II was 2.35, and the median follow-up was 11.1 years. The risk score showed 72.7% overall discriminatory ability as measured by Harrell’s concordance statistic. It showed satisfactory calibration at 10, 15 and 20 years of follow-up. The risk score showed a time-varying nonlinear effect, and accordingly, adjusted long-term survival predictions were calculated. There were subgroups (scores < 50 points) with favorable 20-year survival rates ranging from 77% to 60%. Higher risk subgroups (scores > 90 points) showed poor 20-year survival rates ranging from 22% to 4%. Conclusions: The validated risk score represents a useful algorithm for the detection of patients who could benefit after CABG-BITA with respect to long-term survival. Although further multi-center studies are required worldwide to reveal the usefulness of this score in the clinical setting, its wide adoption may act as a motivation for cardiac surgeons resulting in higher numbers of CABG-BITA procedures.
本研究旨在验证一种当代列线图在预测双侧胸廓内动脉移植的单纯冠状动脉旁路移植术(CABG-BITA)后长期生存情况时的外部有效性。方法:纳入在单一中心接受CABG-BITA的连续患者。原始风险评分的所有预测因素(年龄、糖尿病、慢性阻塞性肺疾病、充血性心力衰竭、慢性肾衰竭、陈旧性心肌梗死、射血分数、主动脉内球囊反搏和外周动脉疾病)均可供分析。结果:在2846例连续患者中,在31383患者年的随访期间共记录到1176例(41.3%)死亡。欧洲心脏手术风险评估系统(EuroSCORE)II的中位数为2.35,中位随访时间为11.1年。根据Harrell一致性统计量,风险评分显示总体辨别能力为72.7%。在随访10年、15年和20年时显示出令人满意的校准。风险评分显示出随时间变化的非线性效应,因此计算了调整后的长期生存预测值。存在20年生存率良好(范围从77%至60%)的亚组(评分<50分)。高风险亚组(评分>90分)显示20年生存率较差(范围从22%至4%)。结论:经过验证的风险评分代表了一种有用的算法,可用于检测在CABG-BITA后可能在长期生存方面获益的患者。尽管需要在全球范围内进行进一步的多中心研究以揭示该评分在临床环境中的有用性,但其广泛采用可能会激励心脏外科医生,从而导致更多的CABG-BITA手术。